Promore Pharma AB (8T00) Stock Statistics & Valuation Metrics
Total Valuation
Promore Pharma AB has a market cap or net worth of EUR 1.56M. The enterprise value is EUR 100.71M.
- Market Cap
- EUR 1.56M
- Enterprise Value
- EUR 100.71M
Share Statistics
Promore Pharma AB has 25,943,077 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 25,943,077
- Owned by Insiders
- ―
- Owned by Institutions
- ―
Financial Efficiency
Promore Pharma AB’s return on equity (ROE) is ― and return on invested capital (ROIC) is ―.
- Return on Equity (ROE)
- ―
- Return on Assets (ROA)
- ―
- Return on Invested Capital (ROIC)
- ―
- Return on Capital Employed (ROCE)
- ―
- Revenue Per Employee
- ―
- Profits Per Employee
- -11.51M
- Employee Count
- 1
- Asset Turnover
- ―
- Inventory Turnover
- ―
Income Statement
In the last 12 months, Promore Pharma AB had revenue of ― and earned -11.51M in profits. Earnings per share was ―.
- Revenue
- ―
- Gross Profit
- -13.43M
- Operating Income
- -10.60M
- Pretax Income
- ―
- Net Income
- -11.51M
- EBITDA
- -8.66M
- Earnings Per Share (EPS)
- ―
Stock Price Statistics
- Beta
- 4.60
- 52-Week Price Change
- 0.00%
- 50-Day Moving Average
- 0.03
- 200-Day Moving Average
- 0.03
- Relative Strength Index (RSI)
- ―
- Average Volume (3m)
- ―
Important Dates
Promore Pharma AB upcoming earnings date is Nov 27, 2026, TBA (Not Confirmed).
- Last Earnings Date
- Aug 20, 2026
- Next Earnings Date
- Nov 27, 2026
- Ex-Dividend Date
- ―
Balance Sheet
Promore Pharma AB has ― in cash and marketable securities with EUR 714.00K in debt, giving a net cash position of ― billion.
- Cash & Marketable Securities
- ―
- Total Debt
- EUR 714.00K
- Net Cash
- ―
- Net Cash Per Share
- ―
- Tangible Book Value Per Share
- ―
